# Synergy CHC Corp. > Clarifo company profile — qualitative business description generated from > the company's filings. Financial statements, charts and ratios are > available on Clarifo (https://www.clarifo.com/fi/companies/Synergy CHC Corp.). ## Overview Synergy CHC Corp. is a U.S.-based consumer health company built around branded nutraceutical and ready-to-drink products. Its portfolio includes FOCUSfactor, a brain-health supplement line, and Flat Tummy, a lifestyle brand focused on weight-management and related nutritional products. ## Products & services • FOCUSfactor brain-health supplements • FOCUSfactor ready-to-drink beverages • Flat Tummy nutritional and weight-management products • Brand licensing for selected foreign territories - **Nutraceuticals** (88%) — Dietary supplements and related consumer health products sold under the company's brands. - **Ready-to-Drink Beverages** (8%) — Packaged beverage extensions tied to the FOCUSfactor brand. - **License Revenue** (4%) — Royalties or license fees from agreements to expand brands into selected territories. - FOCUSfactor brain-health supplements - FOCUSfactor ready-to-drink beverages - Flat Tummy nutritional and weight-management products - Brand licensing for selected foreign territories ## Customers The company sells to consumers seeking brain-health, wellness, and weight-management products, primarily through branded retail and distribution channels. It also monetizes brand assets through licensing arrangements in selected foreign territories, which broadens reach without requiring direct local retail operations. - **Consumer supplement buyers** (primary) — Buy FOCUSfactor products for brain-health and general wellness use. - **Weight-management consumers** (primary) — Buy Flat Tummy products for lifestyle and nutritional support. - **Ready-to-drink beverage consumers** (secondary) — Buy FOCUSfactor RTDs as a convenient extension of the brand. - **Retail and distribution partners** (secondary) — Place and promote the products across consumer channels. - **International license partners** (emerging) — Use the brands in selected foreign territories under license agreements. - Health-conscious consumers buying supplements for daily use - Consumers seeking weight-management and lifestyle products - Retail and distribution partners carrying branded consumer health items - Foreign licensees using the brands in selected territories - Channel partners that support new product launches and beverage distribution ## Geography Synergy CHC Corp. is headquartered in the United States and appears to generate most of its business through U.S.-based consumer channels. The company also has license revenue tied to selected foreign territories, indicating some international brand reach even where direct operating detail is limited. - United States is the core operating and sales base - Selected foreign territories contribute through licensing - Brand expansion outside the U.S. is part of the growth model - Geographic diversification is limited compared with larger consumer brands ## Strategy The company is focused on extending its existing brands into new markets and launching adjacent products, especially within nutraceuticals and ready-to-drink beverages. It also seeks growth through strategic acquisitions that fit its brand portfolio, using licensing and distribution expansion to broaden reach. - **Expand distribution for FOCUSfactor RTDs** (short-term) — Beverage distribution can widen the brand's reach and add a new consumption occasion. - **Develop and launch new products** (medium-term) — Product extensions help deepen shelf presence and reduce reliance on a single SKU set. - **Expand into selected foreign territories** (medium-term) — Licensing can scale brands internationally with lower direct operating complexity. - **Pursue strategic acquisitions** (medium-term) — Acquisitions can add brands and broaden the consumer health portfolio. - Expand FOCUSfactor distribution, especially RTD beverages - Launch new products and product extensions - Grow the nutraceuticals and RTD verticals together - Use licensing to enter selected foreign territories - Pursue acquisitions that fit the existing brand portfolio ## Risks The business depends on consumer demand, brand execution, and distribution access, so weak sell-through or delayed shipments can quickly affect results. It also carries financing and leverage risk, with interest expense and debt repayments playing a meaningful role in the capital structure. As a consumer health company, it faces competition, promotional pressure, product mix shifts, and the usual regulatory and claims-related scrutiny around supplements and wellness products. - **Customer concentration / non-repeat sell-in** [high] — Management disclosed that a new product sell-in to one customer in 2024 did not repeat in 2025, showing revenue sensitivity to individual orders. - **Distribution and shipment timing** [medium] — Packaging upgrades and shipment delays can move revenue across quarters and distort comparability. - **Leverage and refinancing risk** [high] — The company relies on notes payable and related financing, making interest burden and repayment timing important. - **Regulatory and claims risk** [medium] — Supplements and wellness products can face scrutiny over marketing claims, labeling, and product compliance. - **Promotional and channel competition** [medium] — Consumer health brands compete on shelf space, promotion, and brand awareness, which can affect sell-through. - Demand can swing with product sell-in and retailer ordering patterns - Distribution delays can shift revenue between quarters - Debt and interest expense create financing risk - Consumer health claims face regulatory and reputational scrutiny - Promotional spending and channel competition can pressure execution ## Accounting Revenue recognition is a key accounting area because the company sells products, licenses brands, and may experience timing differences from shipments, sell-in, and contract terms. Investors should also watch accounts receivable allowances, since management identifies them as a critical estimate, and note that EBITDA is a non-GAAP measure that excludes interest, taxes, depreciation, and amortization. Quarter-to-quarter comparability can be affected by product mix, shipment timing, and license revenue recognition. - **Revenue recognition** — Can shift revenue between quarters and affect gross profit - **Accounts receivable allowances** — Can affect net revenue and operating results - **Non-GAAP EBITDA** — May differ materially from GAAP earnings and cash generation - **License revenue timing** — Can increase period-to-period volatility - Revenue recognition for product sales and license agreements - Quarterly timing differences from shipments and sell-in - Accounts receivable allowance estimates - Non-GAAP EBITDA excludes financing and non-cash items - Product mix can change gross profit and reported margins --- *Last updated: 2026-04-29T05:01:05.318905+00:00*